The Galien Forum USA 2019

PANEL
4

Chair
Bengt Samuelsson, MD, PhD
Nobel Laureate
Former President,
Karolinska Institute
Former Chairman, 
Nobel Foundation

Panelists
Amy K. Butler, PhD
President of Biosciences
Thermo Fisher Scientific

Steve Rosenberg
Senior Vice President & General Manager
Oracle Health Sciences

Magnus Settergren, MD, PhD
Assoc Prof and Interventional Cardiologist
Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

Eric Topol, MD
Executive Vice President and Chair
Innovative Medicine Scripps Research
Director & Founder
Scripps Research Translational Institute
Author, Deep Learning

Panel Intro

Sponsored by

The marriage of technology and medicine: Bringing out the best in each other


Chair
Bengt Samuelsson, MD, PhD
Nobel Laureate
Former President,
Karolinska Institute
Former Chairman, 
Nobel Foundation


Dr. ButlerAmy K. Butler, PhD
President of Biosciences
Thermo Fisher Scientific

Amy K. Butler serves as president of Biosciences at Thermo Fisher Scientific, the world leader in serving science. She is the site leader for the Carlsbad, CA campus of Thermo Fisher, which includes over 2,000 employees. Amy has held multiple general management and functional leadership roles at Thermo Fisher, including overseeing marketing & e-business, global customer care and gene expression profiling. Amy joined Invitrogen, then Life Technologies and now part of Thermo Fisher, in 2004.

Amy also has a strong background in consulting and academia. Prior to joining Invitrogen, Amy served as an engagement manager with McKinsey & Co. where she worked predominantly with large pharmaceutical companies on R&D, sales and marketing strategies. Prior to that, Amy was a developmental neuroscientist at the Salk Institute.

An active member of the healthcare business community, Amy serves on the Alliance for Regenerative Medicine’s board of directors and has been recognized with several prominent industry awards, including the Healthcare Businesswomen’s Association Rising Star Award (2014) and was most recently named a finalist for the San Diego Magazine’s 2019 Woman of the Year award. Amy obtained her doctorate in neuroscience from the University of Pennsylvania.


Steve Rosenberg
Senior Vice President & General Manager
Oracle Health Sciences

Steve Rosenberg, senior vice president and general manager of Oracle Health Sciences, has more than 30 years of experience leading development, services, support, and consulting, in addition to significant industry experience in life sciences and healthcare. Some of Rosenberg’s key contributions to the industry include cloud-based solutions including an integrated approach to clinical trial management, new methodologies for patient-reported outcomes, and the introduction of advanced analytics for at-risk healthcare payers and providers.


PJ Magnus Settergren

Magnus Settergren, MD, PhD
Assoc Prof and Interventional Cardiologist
Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

He received his medical training in Germany, Australia and Sweden and has been employed by the Karolinska University hospital and Karolinska Institute since 2002 were he is leading the program for percutaneous structural heart disease interventions.

His main clinical and research interest within the field of structural heart diseases; foremost percutaneous treatment of mitral and aortic valve disease. He has been part of pioneering the research and development of this rapidly evolving field since the beginning in 2002. He is also engaged in numerous start-up companies developing new percutaneous treatment options for valves and other structural heart diseases.


Eric TopolEric Topol, MD
Executive Vice President and Chair
Innovative Medicine Scripps Research
Director & Founder
Scripps Research Translational Institute
Author, Deep Learning

Eric Topol is the Founder and Director of the Scripps Research Translational Institute, Professor, Molecular Medicine, and Executive Vice-President of Scripps Research, As a researcher, he has published over 1200 peer-reviewed articles, with more than 240,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.

In 2016, Topol was awarded a $207M grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program is enrolling 1 million participants in the US. This is in addition to his role as principal investigator for a flagship $35M NIH grant to promote innovation in medicine. Prior to coming to Scripps in 2007, he led the Cleveland Clinic to become the #1 center for heart care and was the founder of a new medical school there. He has been voted as the #1 most Influential physician leader in the United States in a national poll conducted by Modern Healthcare. Besides editing several textbooks, he has published 2 bestseller books on the future of medicine: The Creative Destruction of Medicine and The Patient Will See You Now. His new book Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again came out in 2019. Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies.